Building drug delivery into tissue engineering design
- 1 March 2002
- journal article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 1 (3) , 177-186
- https://doi.org/10.1038/nrd744
Abstract
The creation of efficient methods for manufacturing biotechnology drugs--many of which influence fundamental but complex cell behaviours, such as proliferation, migration and differentiation--is creating new opportunities for tissue repair. Many agents are potent and multifunctional; that is, they produce different effects within different tissues. Therefore, control of tissue concentration and spatial localization of delivery is essential for safety and effectiveness. Synthetic systems that can control agent delivery are particularly promising as materials for enhancing tissue regeneration. This review discusses the state of the art in controlled-release and microfluidic drug delivery technologies, and outlines their potential applications for tissue engineering.Keywords
This publication has 86 references indexed in Scilit:
- Development of growth factor fusion proteins for cell‐triggered drug deliveryThe FASEB Journal, 2001
- Growth-factor-induced healing of partial-thickness defects in adult articular cartilageOsteoarthritis and Cartilage, 2001
- Micro-systems in biomedical applicationsJournal of Micromechanics and Microengineering, 2000
- Cutaneous Wound HealingNew England Journal of Medicine, 1999
- Imaging of Pressure- and Electrokinetically Driven Flows through Open CapillariesAnalytical Chemistry, 1998
- Stabilization of nerve growth factor in controlled release polymers and in tissueJournal of Biomaterials Science, Polymer Edition, 1997
- Distribution of drugs following controlled delivery to the brain interstitiumJournal of Neuro-Oncology, 1995
- Controlled release of TGF-β1 from a biodegradable matrix for bone regenerationJournal of Biomaterials Science, Polymer Edition, 1994
- Tissue EngineeringScience, 1993
- Nerve Fiber Growth on Defined Hydrogel SubstratesScience, 1982